| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/28/2010 | US20100024073 Resistance To Soybean Aphid In Early Maturing Soybean Germplasm |
| 01/28/2010 | US20100024070 Modulation of oil levels in plants |
| 01/28/2010 | US20100024068 Antimicrobial Peptides and Uses Thereof |
| 01/28/2010 | US20100024067 Plants having enhanced seed yield-related traits and a method for making the same |
| 01/28/2010 | US20100024062 Soybean variety d5589654 |
| 01/28/2010 | US20100024059 Soybean variety d5124857 |
| 01/28/2010 | US20100024058 Soybean variety d5862173 |
| 01/28/2010 | US20100024057 Soybean variety d5213471 |
| 01/28/2010 | US20100024056 Soybean variety d5898941 |
| 01/28/2010 | US20100024050 Pufa polyketide synthase systems and uses thereof |
| 01/28/2010 | US20100024049 Digestive System Cancer Stem Cells and Tests and Uses Therefor |
| 01/28/2010 | US20100022766 Biosynthetic gene cluster for the production of a complex polyketide |
| 01/28/2010 | US20100022637 Identification of anti-cancer compounds and compounds for treating huntington's disease and methods of treatment thereof |
| 01/28/2010 | US20100022628 Alternative oxidase and uses thereof |
| 01/28/2010 | US20100022626 Modulators of cell migration and methods of identifying same |
| 01/28/2010 | US20100022622 Dbait and its Standalone Uses Thereof |
| 01/28/2010 | US20100022592 Thiazole derivatives as modulators of g protein-coupled receptors |
| 01/28/2010 | US20100022533 Compositions and methods for inducing cell dedifferentiation |
| 01/28/2010 | US20100022519 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 01/28/2010 | US20100022507 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/28/2010 | US20100022499 Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads |
| 01/28/2010 | US20100022453 NoGo Receptor 1 and Fibroblast Growth Factor Interactions |
| 01/28/2010 | US20100022452 Nanobodies for the treatment of aggregation-mediated disorders |
| 01/28/2010 | US20100022401 Avidin-like proteins from symbiotic bacteria |
| 01/28/2010 | US20100022005 Adipose stromal stem cells for tissue and vascular modification |
| 01/28/2010 | US20100022004 Modified reconstituted basement membrane composition for assay system |
| 01/28/2010 | US20100022003 Therapeutic cell medicine comprising skin tissue derived stem cell |
| 01/28/2010 | US20100022002 Method for inhibiting the formation of set1 family core complexes |
| 01/28/2010 | US20100022001 Cationic Liposomes And Method of Use |
| 01/28/2010 | US20100022000 Increasing Cell Culture Population Doublings for Long-Term Growth of Finite Life Span Human Cell Cultures |
| 01/28/2010 | US20100021999 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
| 01/28/2010 | US20100021998 Defined cell culturing surfaces and methods of use |
| 01/28/2010 | US20100021997 Biologically active recombinant human saposin C and PSAP |
| 01/28/2010 | US20100021996 Genetically Altered Anti-body Producing Cell Lines With Improved Antibody Characteristics |
| 01/28/2010 | US20100021995 Biological products |
| 01/28/2010 | US20100021991 Methods for Producing Modified Glycoproteins |
| 01/28/2010 | US20100021976 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/28/2010 | US20100021965 Protein Expression in Rodent Cells |
| 01/28/2010 | US20100021963 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 01/28/2010 | US20100021935 Goodpasture Antigen Binding Protein and Its Detection |
| 01/28/2010 | US20100021931 Fluorescence based reporter construct for the direct detection of TGF-beta receptor activation and modulators thereof |
| 01/28/2010 | US20100021927 Cholesterol loaded insect cell membranes as test systems for abc transporter proteins |
| 01/28/2010 | US20100021921 Mutated abl kinase domains |
| 01/28/2010 | US20100021920 Mutated abl kinase domains |
| 01/28/2010 | US20100021912 Methods of Modulating Lipid Concentrations in Eukaryotic Cells |
| 01/28/2010 | US20100021911 Production host cell lines |
| 01/28/2010 | US20100021866 Method of producing tooth, set of teeth, and method of producing tissue |
| 01/28/2010 | US20100021612 Method for the production of fusion proteins in transgenic mammal milk |
| 01/28/2010 | US20100021499 Cell-based systems for producing influenza vaccines |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021479 Monoclonal Antibodies Against CD30 Lacking in Fucosyl Residues |
| 01/28/2010 | US20100021478 Diagnostic antibody assay |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021474 Methods and compositions for targeting hepsin |
| 01/28/2010 | US20100021473 Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021466 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies |
| 01/28/2010 | US20100021465 Boris isoforms and methods of detecting and treating disease |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | US20100021452 Compositions and methods of use for therapeutic antibodies |
| 01/28/2010 | US20100021448 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 01/28/2010 | US20100021443 Method of preparing lung alveolar epithelial type ii cells derived from embryonic stem cells |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021438 Kidney derived stem cells and methods for their isolation, differentiation and use |
| 01/28/2010 | US20100021437 Neural stem cells derived from induced pluripotent stem cells |
| 01/28/2010 | US20100021436 Multipotent adult stem cell derived from canine umbilical cord blood, placenta and canine fetus heart, method for preparing the same and cellular therapeutics containing the same |
| 01/28/2010 | US20100021435 Pancreatic islet-like cells |
| 01/28/2010 | US20100021434 Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS Diseases |
| 01/28/2010 | US20100021423 Heterocyclic antiviral compounds |
| 01/28/2010 | US20100021421 Fusion proteins and methods for modulation of immune response |
| 01/28/2010 | US20100021387 Methods for Inducing Reversible Stasis |
| 01/28/2010 | CA2768737A1 Improved vegetable oils and uses therefor |
| 01/28/2010 | CA2731821A1 Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use |
| 01/28/2010 | CA2731767A1 Differentiated anucleated cells and method for preparing the same |
| 01/27/2010 | EP2147973A1 Gene-disrupted strain, recombinant plasmid, transformant and method of producing 3-carboxymuconolactone |
| 01/27/2010 | EP2147971A2 Defined cell culturing surfaces and methods of use |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP2147594A1 Antibody producing non-human mammals |
| 01/27/2010 | EP2147095A2 Methods and apparatuses for separating biological particles |
| 01/27/2010 | EP2147094A1 Stem cell-derived retinal pigment epithelial cells |
| 01/27/2010 | EP2146756A2 Partially degradable scaffolds for biomedical applications |
| 01/27/2010 | EP2146742A2 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods |
| 01/27/2010 | EP2146728A2 Progenitor cells from urine and methods for using the same |
| 01/27/2010 | EP2146575A1 Influenza polynucleotides, expression constructs, compositions, and methods of use |
| 01/27/2010 | EP1812562B1 Method for preparation of an autologous endometrial culture for an endometrium/embryo coculture |
| 01/27/2010 | EP1704227B1 Immortalized hepatocytes |
| 01/27/2010 | EP1407202B1 Cryopreservation system and method with controlled dendritic freezing front velocity |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | EP1234875B1 Novel metalloprotease having aggrecanase activity |
| 01/27/2010 | EP1206563B1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 01/27/2010 | EP1191937B1 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 01/27/2010 | EP1026941B1 Nepovirus resistance in grapevine |
| 01/27/2010 | CN101633907A Amplification culture method for antigen specific cytotoxic t lymphocytes |
| 01/27/2010 | CN101633903A Generating method for synchronously regulating and controlling somatic embryos of coniferous trees and culture medium thereof |
| 01/27/2010 | CN101633902A In-vitro pollen germination liquid medium of balloon flower and method using same to determine pollen viability thereof |
| 01/27/2010 | CN100584947C Nucleotide sequence with internal ribosome entry site (IRES) effect |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |